Added to YB: 2026-01-14
Pitch date: 2025-11-11
ECOR [bullish]
electroCore, Inc.
-0.16%
current return
Author Info
No bio for this author
Company Info
electroCore, Inc., a bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation (“nVNS”) technology platform in the United States, the United Kingdom, and internationally.
Market Cap
$45.0M
Pitch Price
$6.30
Price Target
12.00 (+90%)
Dividend
N/A
EV/EBITDA
-3.55
P/E
-3.30
EV/Sales
1.44
Sector
Health Care Equipment and Supplies
Category
growth
electroCore, Inc. - $ECOR
ECOR: Neuromodulation co w/ 3 FDA-cleared platforms (gammaCore, Truvaga, Quell) addressing $600M+ nVNS market. 86% gross margins, $13M cash, path to EBITDA+ by 2H 2026. Q3 record $8.7M rev (+33% YoY), VA expansion, Quell exceeding expectations. Trades 0.8x 2025E sales vs peers at 3-5x. $12 price target = 100% upside.
Read full article (4 min)